HbA1C Point of Care Machine

DxGEN is global Point-Of-Care(POC) diagnostics company. Our goal is to help make clinical decisions in the care and treatment of patients at the time and place. We are committed to applying leading-edge technology for high-quality products. We endeavour to be a global leader and deliver technical innovation continuously.

DxGen devoted to developing multi-marker for people with diabetes and tuberculosis. We provide total solution and offers tools and services to help developing POC products from concept through commercialization. Healthcare professionals will have reliable test results in minutes with the lab quality precision and accuracy while operating cost effectively.

Founders and leadership of the company are an experienced team composed of industry leaders with successful track records. A powerful combined team with strong R & D capabilities and experience is what truly drives innovation. We are building a global investor, strategic partner and customer base and plan to manufacture components in multiple locations worldwide.

Glycated Albumin and HbA1c are index of average glucose over the preceding weeks-to-months. They are the results of glycation when glucose molecules spontaneously react with the amine group of proteins by non-enzymatic reaction. If glucose level remains high, then level of Glycated Albumin and HbA1c increases.

FPG: Measuring the blood glucose at a single point in time.

Glycated Albumin: Measuring the average blood glucose level over the past 2-4 weeks. It is an intermediate marker for glycemic control because of shorter half-life than HbA1c.

HbA1c: Measuring the average blood glucose level over the past 2-4 months as long-term marker.

There was mild decrease in % HbA1c, while % Glycated Albumin decreased markedly after intensive insulin therapy. Glycated Albumin is thought to be more sensitive to short-term fluctuations in glucose level and rapidly confirms treatment efficacy due to half-life. When glycemic control changes shortly by starting or changing of diabetes treatment, Glycated Albumin is a more suitable marker than HbA1c.